These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10695689)

  • 21. Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly.
    Tuomilehto J
    Am J Med; 1991 Mar; 90(3A):34S-41S. PubMed ID: 2006658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
    Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
    Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial.
    Oxlund CS; Pareek M; Rasmussen BSB; Vaduganathan M; Biering-Sørensen T; Byrne C; Almarzooq Z; Olsen MH; Bhatt DL
    Am J Med; 2019 Jul; 132(7):840-846. PubMed ID: 30721655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of overall obesity and body fat distribution in predicting risk of mortality.
    Reis JP; Macera CA; Araneta MR; Lindsay SP; Marshall SJ; Wingard DL
    Obesity (Silver Spring); 2009 Jun; 17(6):1232-9. PubMed ID: 19197258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
    Petrovitch H; Vogt TM; Berge KG
    Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group.
    J Clin Epidemiol; 1988; 41(12):1197-208. PubMed ID: 2905387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
    Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
    JAMA; 2002 Sep; 288(12):1491-8. PubMed ID: 12243636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body-mass index and mortality in Korean men and women.
    Jee SH; Sull JW; Park J; Lee SY; Ohrr H; Guallar E; Samet JM
    N Engl J Med; 2006 Aug; 355(8):779-87. PubMed ID: 16926276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
    Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
    Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
    JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body mass index and the risk of stroke in men.
    Kurth T; Gaziano JM; Berger K; Kase CS; Rexrode KM; Cook NR; Buring JE; Manson JE
    Arch Intern Med; 2002 Dec 9-23; 162(22):2557-62. PubMed ID: 12456227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
    N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conclusions and implications of the systolic hypertension in the elderly program.
    Moyé LA; Davis BR; Hawkins CM; Probstfield JL
    Clin Exp Hypertens; 1993 Nov; 15(6):911-24. PubMed ID: 8268898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.